newsclinical trialEltrombopag
新诊断的儿童免疫性血小板减少症中使用艾曲波帕：早期治疗策略的突破
By MedXY|Oct 24, 2025
这项随机试验表明，艾曲波帕显著改善了新诊断为ITP的儿童的持续血小板反应，提供了一种潜在的早期干预选择。
MedXY News
EnglishTagthrombopoietin receptor agonist
2 · 20 / page
Ask MedXY AI
2 · 20 / page
Tag
This randomized trial demonstrates that eltrombopag significantly improves sustained platelet response in children with newly diagnosed ITP, offering a potential early intervention option.
